RIPK1 Drives JAK1‐STAT3 Signaling to Promote CXCL1‐Mediated Neutrophil Recruitment in Sepsis‐Induced Lung Injury
Advanced Science · 2025-12 · 12 (45)
DOI: 10.1002/advs.202507123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 15.09.2025. Verfasst von Hao Sun und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. Hauptthemen laut MEDLINE: Sepsis, Receptor-Interacting Protein Serine-Threonine Kinases, STAT3 Transcription Factor, Neutrophil Infiltration. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Program of Shanghai Academic Research Leader, Shanghai "Yiyuan New Star" Outstanding Youth Medical Talent Program.
Themen: Sepsis
Abstract (Originalsprache)
Sepsis‐induced lung injury, characterized by unregulated inflammation and impaired alveolar epithelial integrity, significantly contributes to sepsis‐related mortality. Although receptor‐interacting serine/threonine‐protein kinase 1 (RIPK1) is critical in regulating necroptosis and inflammation, its precise contribution to sepsis‐induced lung injury remains poorly understood. In this study, selective activation of RIPK1 in type II alveolar epithelial cells (AECs) is observed during sepsis. CXCL1 is identified as a critical downstream target of RIPK1 through integrative transcriptomic and proteomic analyses. Mechanistically, RIPK1 interacts with JAK1 to induce STAT3 phosphorylation, facilitate its nuclear translocation, and promote its binding to the Cxcl1 promoter, thereby upregulating its expression and driving excessive neutrophil recruitment. Genetic or pharmacological inhibition of RIPK1 attenuated CXCL1 production, neutrophil infiltration, and alveolar damage, improving survival in septic mice. Compound 62, a selective RIPK1 inhibitor, has demonstrated efficacy in attenuating systemic inflammatory cascades, preserving epithelial barrier integrity, and improving survival rates in mice. These findings establish RIPK1 as a therapeutic target in sepsis‐induced lung injury and redefine alveolar epithelial cells as positive contributors to inflammatory amplification. This work advances precision strategies to mitigate sepsis‐induced lung injury, addressing a critical unmet need in critical care medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
- Shanghai Key laboratory of Perioperative Stress and Protection, Shanghai, 200032, China.
- Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, 201210, China.
- Infectious Diseases Unit, Tel Aviv Sourasky Medical Center, Faculty of Medicine, Tel Aviv University, Tel Aviv, 6997801, Israel.
- Department of Integrative Medicine and Neurobiology, School of Basic Medical Science, State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai, 200032, China.
- Department of Anesthesiology, Shanghai Geriatric Medical Center, Shanghai, 201104, China.
ORCID-Profile: Wankun Chen
Förderung
- National Natural Science Foundation of China
- Program of Shanghai Academic Research Leader
- Shanghai "Yiyuan New Star" Outstanding Youth Medical Talent Program
- Shanghai Sailing Program
- Development Project of Shanghai Peak Disciplines-Integrated Chinese and Western Medicine, and the Shanghai Key Laboratory for Acupuncture Mechanism and Acupoin…
- Xinjiang Science and Technology Support Project
- "Tianshan Elite" Medical and Health High-Level Talent Training Program
- Shanghai Basic Research Pioneer Project and Shanghai Municipal Science and Technology Major Project.
Zitieren
APA
Sun, H., Li, X., Gao, S., Jiang, Y., Wu, X., Chen, Z., Wu, H., Hua, Q., Zu, R., Xiang, H., Ben-Ami, R., Miao, C., Tan, L., Li, Y., Wang, J., & Chen, W. (2025). RIPK1 Drives JAK1‐STAT3 Signaling to Promote CXCL1‐Mediated Neutrophil Recruitment in Sepsis‐Induced Lung Injury. Advanced Science, 12(45). https://doi.org/10.1002/advs.202507123
Vancouver
Sun H, Li X, Gao S, Jiang Y, Wu X, Chen Z, et al. RIPK1 Drives JAK1‐STAT3 Signaling to Promote CXCL1‐Mediated Neutrophil Recruitment in Sepsis‐Induced Lung Injury. Advanced Science. 2025;12(45). doi:10.1002/advs.202507123
BibTeX
@article{Sun2025,
author = {Sun, Hao and Li, Xiya and Gao, Shenjia and Jiang, Yi and Wu, Xinyi and Chen, Zhaoyuan and Wu, Han and Hua, Qing and Zu, Rui and Xiang, Huaijiang and Ben-Ami, Ronen and Miao, Changhong and Tan, Li and Li, Ying and Wang, Jun and Chen, Wankun},
title = {RIPK1 Drives JAK1‐STAT3 Signaling to Promote CXCL1‐Mediated Neutrophil Recruitment in Sepsis‐Induced Lung Injury},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {45},
doi = {10.1002/advs.202507123}
}
EUVIMED